$GRAL
GRAIL, Inc.
Nasdaq · Healthcare · Services-Medical Laboratories · Sunnyvale, CA
GRAL chart
What traders are saying about $GRAL
Latest postsGRAIL, Inc. news
- Her Doctor Will Order a $949 Blood Test That Screens for Multiple Cancers. Medicare Will Pay $0 Toward the Test, Leaving Her With the Entire Bill Before Any Coverage Decision in 2029
24/7 Wall St. ·
- Kobe Bryant’s China-Exclusive Grail Is Finally Coming Stateside After 13 Years
Men's Journal ·
- GRAIL Inc (GRAL) (Q3 2026) Earnings Call Highlights: FDA Nod on the Horizon as Galleri Gains ...
Yahoo Finance ·
- SpaceX to attempt 'holy grail of rocketry' by catching both Starship stages
Florida Today ·
- 'Promising' heart attack study could be 'holy grail for cardiologists'
Daily Record ·
- You Don’t Need a $100 Face Cream—This $15 Find Is “Instant Botox,” Say Over-60 Fans of This “Holy Grail”
Real Simple ·
- The Way of the Holy Grail closes its internationalization programme in Valencia with a conference with the AIUTA
24-7PressRelease.com ·
- Lululemon shoppers say this 'holy grail' bag is 'perfect for work, travel or the gym' — it's under $200
Yahoo Lifestyle Canada ·
- GRAIL (GRAL) Could Be 8% Undervalued On Galleri FDA Momentum
Simply Wall St ·
- Heart pill hailed as 'Holy Grail' after high blood pressure patients were effectively cured of deadly condition in pivotal trial
Daily Mail ·
- 'Holy grail' long lost board game found in attic
BBC ·
- Reviewers Confirm: These 27 Beauty Products Are “Holy Grail” Status
BuzzFeed ·
GRAIL, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $147.2M | $125.6M | $93.1M | $55.5M |
| Net income | -$408.4M | -$2.03B | -$1.47B | -$5.40B |
| Diluted EPS | $-11.11 | $-63.54 | $-47.21 | $-173.89 |
| Total assets (year end) | $2.92B | $2.98B | $3.91B | – |
| Cash and equivalents (year end) | $249.7M | $214.2M | $97.3M | $241.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About GRAIL, Inc.
- Ticker
- GRAL (Nasdaq)
- Industry
- Services-Medical Laboratories
- Headquarters
- Sunnyvale, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1699031
- Former names
- GRAIL, LLC
Frequently asked questions
What exchange is GRAIL, Inc. listed on?
GRAIL, Inc. trades on the Nasdaq under the ticker symbol GRAL.
What industry is GRAIL, Inc. in?
GRAIL, Inc. is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.
Where is GRAIL, Inc. headquartered?
GRAIL, Inc.'s business address on file with the SEC is in Sunnyvale, CA.
When does GRAIL, Inc.'s fiscal year end?
GRAIL, Inc.'s fiscal year ends on December 31.
How much revenue did GRAIL, Inc. report?
GRAIL, Inc. reported $147.2M in revenue for calendar year 2025, according to its SEC filings.